Related Experiment Videos
Clinical variability within Brachmann-de Lange syndrome: a proposed classification system
M I Van Allen1, G Filippi, J Siegel-Bartelt
1Department of Medical Genetics, University Hospital-Shaughnessy Site, University of British Columbia, Vancouver, Canada.
American Journal of Medical Genetics
|November 15, 1993
Summary
This study proposes a new classification for Brachmann-de Lange syndrome (BDLS), categorizing patients into Type I (classic), Type II (mild), and Type III (phenocopies) based on severity and cause. This framework aids in understanding the diverse clinical presentations of BDLS.
Area of Science:
- Genetics and Developmental Biology
- Clinical Medicine
- Pediatric Neurology
Background:
- Brachmann-de Lange syndrome (BDLS) is a complex genetic disorder with varied clinical manifestations.
- Accurate classification is crucial for diagnosis, management, and research.
- Previous classification systems may not fully capture the spectrum of BDLS phenotypes.
Observation:
- Seven patients with BDLS, including familial cases, were analyzed to develop a new classification system.
- Type I (classic) BDLS is characterized by severe prenatal and postnatal growth deficiency, profound psychomotor retardation, and major malformations.
- Type II (mild) BDLS presents with milder facial and skeletal anomalies, less severe growth deficits, and mild to borderline psychomotor delays, often with behavioral issues.
- Type III (phenocopies) encompasses individuals with BDLS-like features due to chromosomal abnormalities or teratogenic exposures.
Findings:
- A proposed three-tiered classification system (Type I, II, III) effectively differentiates BDLS subtypes.
- Key distinguishing features include the severity of growth deficiency, psychomotor retardation, and presence/absence of major malformations.
- Type III highlights the importance of considering external factors and chromosomal anomalies in BDLS-like presentations.
Implications:
- This classification system provides a more refined approach to diagnosing and understanding BDLS.
- It can facilitate targeted therapeutic strategies and genetic counseling for affected families.
- Further research is warranted to validate this classification and explore genotype-phenotype correlations.